- Home
- VIR vs ZD Comparison
VIR vs ZD Comparison
Compare VIR & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VIR | ZD |
|---|---|---|
| Founded | 2016 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | VIR | ZD |
|---|---|---|
| Price | $8.82 | $53.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $19.43 | ★ $39.71 |
| AVG Volume (30 Days) | ★ 1.6M | 511.5K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | $68,556,000.00 | ★ $1,364,028,000.00 |
| Revenue This Year | $270.22 | N/A |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | ★ N/A | $86.36 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $22.45 |
| 52 Week High | $11.66 | $55.46 |
Technical Indicators
Market Signals| Indicator | VIR | ZD |
|---|---|---|
| Relative Strength Index (RSI) | 42.38 | 46.11 |
| Support Level | $8.43 | $50.68 |
| Resistance Level | $10.33 | $54.86 |
| Average True Range (ATR) | 0.45 | 1.89 |
| MACD | -0.02 | -0.31 |
| Stochastic Oscillator | 20.78 | 10.87 |
Price Performance
Historical ComparisonAbout VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
About ZD Ziff Davis Inc.
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.